1
|
Lee YS, Park YR, Lee HB, Park HJ, Lee HE, Kim GA, Kim SH, Shin JH. The preventive effect of Gastrodia elata Blume extract on vancomycin-induced acute kidney injury in rats. Lab Anim Res 2024; 40:14. [PMID: 38589968 PMCID: PMC11000351 DOI: 10.1186/s42826-024-00200-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2023] [Revised: 03/14/2024] [Accepted: 03/20/2024] [Indexed: 04/10/2024] Open
Abstract
BACKGROUND Gastrodia elata Blume (GEB), a traditional medicinal herb, has been reported to have pharmacological effect including protection against liver, neuron and kidney toxicity. However, explanation of its underlying mechanisms remains a great challenge. This study investigated the protective effects of GEB extract on vancomycin (VAN)-induced nephrotoxicity in rats and underlying mechanisms with emphasis on the anti-oxidative stress, anti-inflammation and anti-apoptosis. The male Sprague-Dawley rats were randomly divided three groups: control (CON) group, VAN group and GEB group with duration of 14 days. RESULTS The kidney weight and the serum levels of blood urea nitrogen and creatinine in the GEB group were lower than the VAN group. Histological analysis using hematoxylin & eosin and periodic acid Schiff staining revealed pathological changes of the VAN group. Immunohistochemical analysis revealed that the expression levels of N-acetyl-D-glucosaminidase, myeloperoxidase and tumor necrosis factor-alpha in the GEB group were decreased when compared with the VAN group. The number of terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling-positive cells, phosphohistone and malondialdehyde levels were lower in the GEB group than VAN group. The levels of total glutathione in the GEB group were higher than the VAN group. CONCLUSIONS The findings of this study suggested that GEB extract prevents VAN-induced renal tissue damage through anti-oxidation, anti-inflammation and anti-apoptosis.
Collapse
Affiliation(s)
- Yeon Su Lee
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea
- Department of Biomedical Laboratory Science, Eulji University, Seongnam, 13135, Korea
| | - Yu Rim Park
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea
- Department of Biomedical Laboratory Science, Eulji University, Seongnam, 13135, Korea
| | - Hyo Bin Lee
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea
- Department of Biomedical Laboratory Science, Eulji University, Seongnam, 13135, Korea
| | - Hye Joon Park
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea
- Department of Biomedical Laboratory Science, Eulji University, Seongnam, 13135, Korea
| | - Ha Eun Lee
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea
- Department of Biomedical Laboratory Science, Eulji University, Seongnam, 13135, Korea
| | - Geon A Kim
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea
- Department of Biomedical Laboratory Science, Eulji University, Uijeongbu, 11759, Korea
| | - Sang-Hoon Kim
- Department of Internal Medicine, Eulji Hospital, Seoul, 01830, Korea.
- Eulji Medi-Bio Research Institute, Eulji University School of Medicine, Seoul, 01830, Korea.
| | - Jae-Ho Shin
- Department of Senior Healthcare, Eulji University, Uijeongbu, 11549, Korea.
- Department of Biomedical Laboratory Science, Eulji University, Seongnam, 13135, Korea.
- Eulji Medi-Bio Research Institute, Eulji University School of Medicine, Seoul, 01830, Korea.
| |
Collapse
|
2
|
Blood Biomarkers and Metabolomic Profiling for the Early Diagnosis of Vancomycin-Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis of Experimental Studies. J Pers Med 2022; 12:jpm12091397. [PMID: 36143182 PMCID: PMC9505572 DOI: 10.3390/jpm12091397] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2022] [Revised: 08/25/2022] [Accepted: 08/26/2022] [Indexed: 11/22/2022] Open
Abstract
Background: several blood-based biomarkers have been proposed for predicting vancomycin-associated kidney injury (VIKI). However, no systematic analysis has compared their prognostic value. Objective: this systematic review and meta-analysis was designed to investigate the role of blood biomarkers and metabolomic profiling as diagnostic and prognostic predictors in pre-clinical studies of VIKI. Methods: a systematic search of PubMed was conducted for relevant articles from January 2000 to May 2022. Animal studies that administered vancomycin and studied VIKI were eligible for inclusion. Clinical studies, reviews, and non-English literature were excluded. The primary outcome was to investigate the relationship between the extent of VIKI as measured by blood biomarkers and metabolomic profiling. Risk of bias was assessed with the CAMARADES checklist the SYRCLE’s risk of bias tool. Standard meta-analysis methods (random-effects models) were used. Results: there were four studies for the same species, dosage, duration of vancomycin administration and measurement only for serum creatine and blood urea nitrogen in rats. A statistically significant increase was observed between serum creatinine in the vancomycin group compared to controls (pooled p = 0.037; Standardized Mean Difference: 2.93; 95% CI: 0.17 to 5.69; I2 = 92.11%). Serum BUN levels were not significantly different between control and vancomycin groups (pooled p = 0.11; SMD: 3.05; 95% CI: 0.69 to 6.8; I2 = 94.84%). We did not identify experimental studies using metabolomic analyses in animals with VIKI. Conclusions: a total of four studies in rodents only described outcomes of kidney injury as defined by blood biomarkers. Blood biomarkers represented included serum creatinine and BUN. Novel blood biomarkers have not been explored.
Collapse
|
3
|
Pulakat L, Chen HH, Gavini MP, Ling LA, Tang Y, Mehm A, Martin GL, Beale CN, Mooney BP, Sun H. Transdermal Delivery of High Molecular Weight Antibiotics to Deep Tissue Infections via Droplette Micromist Technology Device (DMTD). Pharmaceutics 2022; 14:976. [PMID: 35631562 PMCID: PMC9146216 DOI: 10.3390/pharmaceutics14050976] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 04/24/2022] [Accepted: 04/27/2022] [Indexed: 02/05/2023] Open
Abstract
Wound infection by multidrug-resistant (MDR) bacteria is a major disease burden. Systemic administration of broad-spectrum antibiotics colistin methanesulfonate (CMS) and vancomycin are the last lines of defense against deep wound infections by MDR bacteria. However, systemic administration of CMS and vancomycin are linked to life-threatening vital organ damage. Currently there are no effective topical application strategies to deliver these high molecular weight antibiotics across the stratum corneum. To overcome this difficulty, we tested if high molecular weight antibiotics delivered by Droplette micromist technology device (DMTD), a transdermal delivery device that generates a micromist capable of packaging large molecules, could attenuate deep skin tissue infections. Using green fluorescent protein-tagged E. coli and live tissue imaging, we show that (1) the extent of attenuation of deep-skin E. coli infection was similar when treated with topical DMTD- or systemic IP (intraperitoneal)-delivered CMS; (2) DMTD-delivered micromist did not spread the infection deeper; (3) topical DMTD delivery and IP delivery resulted in similar levels of vancomycin in the skin after a 2 h washout period; and (4) IP-delivered vancomycin was about 1000-fold higher in kidney and plasma than DMTD-delivered vancomycin indicating systemic toxicity. Thus, topical DMTD delivery of these antibiotics is a safe treatment for the difficult-to-treat deep skin tissue infections by MDR bacteria.
Collapse
Affiliation(s)
- Lakshmi Pulakat
- Tufts Medical Center, Molecular Cardiology Research Institute, Boston, MA 02111, USA; (H.H.C.); (L.A.L.); (Y.T.); (A.M.); (G.L.M.)
- School of Medicine, Tufts University, Boston, MA 02111, USA;
- Division of Cardiovascular Medicine, Department of Medicine, University of Missouri, Columbia, MO 65211, USA
| | - Howard H. Chen
- Tufts Medical Center, Molecular Cardiology Research Institute, Boston, MA 02111, USA; (H.H.C.); (L.A.L.); (Y.T.); (A.M.); (G.L.M.)
- School of Medicine, Tufts University, Boston, MA 02111, USA;
| | | | - Lauren A. Ling
- Tufts Medical Center, Molecular Cardiology Research Institute, Boston, MA 02111, USA; (H.H.C.); (L.A.L.); (Y.T.); (A.M.); (G.L.M.)
- School of Medicine, Tufts University, Boston, MA 02111, USA;
| | - Yinian Tang
- Tufts Medical Center, Molecular Cardiology Research Institute, Boston, MA 02111, USA; (H.H.C.); (L.A.L.); (Y.T.); (A.M.); (G.L.M.)
| | - Alexander Mehm
- Tufts Medical Center, Molecular Cardiology Research Institute, Boston, MA 02111, USA; (H.H.C.); (L.A.L.); (Y.T.); (A.M.); (G.L.M.)
| | - Gregory L. Martin
- Tufts Medical Center, Molecular Cardiology Research Institute, Boston, MA 02111, USA; (H.H.C.); (L.A.L.); (Y.T.); (A.M.); (G.L.M.)
| | | | - Brian P. Mooney
- Charles W. Gehrke Proteomics Center, Division of Biochemistry, University of Missouri, Columbia, MO 65211, USA;
| | - Hongmin Sun
- Division of Cardiovascular Medicine, Department of Medicine, University of Missouri, Columbia, MO 65211, USA
| |
Collapse
|
4
|
Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model. Antimicrob Agents Chemother 2021; 65:AAC.02141-20. [PMID: 33526494 DOI: 10.1128/aac.02141-20] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Accepted: 01/25/2021] [Indexed: 12/28/2022] Open
Abstract
The risk of vancomycin (VAN)-associated acute kidney injury (AKI) may be altered with combination regimens. The specific AKI risk when VAN is combined with imipenem-cilastatin/relebactam (IMP-C/REL) or piperacillin/tazobactam (TZP) has not been clearly defined. We sought to quantify the dose-AKI relationships of VAN alone and in combination with TZP or IMP-C/REL. Male C57BL/6J mice (Charles River Laboratory) aged 10 to 12 weeks were dosed with study drug regimens in three stages. Stage 1 consisted of a VAN dose-ranging design (0 to 600 mg/kg daily) over a 7-day period to identify the VAN monotherapy dose-AKI relationship in the murine model. Stage 2 evaluated the approximate VAN dose eliciting 50% AKI response in stage 1 in combination with the highest human equivalent doses (HEDs) used in preclinical murine models (2.5 and 320 mg/kg daily for TZP and IMP-C/REL, respectively). Stage 3 tested these combinations with fractionated doses of TZP or IMP-C/REL administered at 6- and 12-h intervals. In these studies, AKI was defined with biomarkers (serum creatinine [SCr], blood urea nitrogen [BUN]) and with histopathological assessment by a treatment-blinded pathologist. VAN doses of 300 to 500 mg/kg daily reproducibly led to development of AKI within 4 days of dosing. Mice treated with VAN alone had a near doubling of their baseline SCr and BUN levels compared with mice treated with control, IMP-C/REL alone, or TZP alone. Both VAN+IMP-C/REL and VAN+TZP had significantly (P < 0.05) lower SCr and BUN values than VAN alone when dosed once daily. This nephroprotective effect was retained with VAN+IMP-C/REL but not VAN+TZP when IMP-C/REL and TZP were administered every 6 h. Biomarker results were concordant with histopathological findings. The VAN dose-AKI relationship can be attenuated with single daily HEDs of TZP or IMP-C/REL in mice. IMP-C/REL, but not TZP, retained a nephroprotective effect compared with VAN monotherapy when administered as fractionated doses.
Collapse
|
5
|
Takigawa M, Yatsu T, Takino Y, Matsumoto S, Kitano T, Lee J, Arai T, Tanaka H, Ishii T, Mori Y, Ishigami A. High-Dose Vitamin C Preadministration Reduces Vancomycin-Associated Nephrotoxicity in Mice. J Nutr Sci Vitaminol (Tokyo) 2020; 65:399-404. [PMID: 31666476 DOI: 10.3177/jnsv.65.399] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
Vancomycin is recommended for treating severe infections caused by Gram-positive cocci, including methicillin-resistant Staphylococcus aureus. However, renal damage often occurs as a side effect because vancomycin is mainly excreted via the kidneys. The mechanism of vancomycin-associated nephrotoxicity is thought to involve the elevation of oxidative stress in the kidneys. Vitamin C (VC) has strong antioxidant properties; therefore, we evaluated the effect of high-dose VC preadministration on vancomycin-associated nephrotoxicity. Vancomycin was intraperitoneally injected into mice once daily for 7 d. Additionally, high-dose VC was intraperitoneally injected into mice at 30 min before vancomycin administration for 7 d. The plasma creatinine and urea nitrogen levels were increased by vancomycin treatment; however, high-dose VC preadministration suppressed the increase in these levels. Histological examination also revealed that high-dose VC preadministration reduced the characteristics of vancomycin-associated nephrotoxicity, such as dilated renal tubules with casts, the dilation of renal proximal tubules, and tubular epithelial desquamation. Furthermore, high-dose VC preadministration reduced the appearance of apoptotic cells presumably derived from the epithelial cells in the dilated proximal tubules. Thus, intraperitoneally injected high-dose VC preadministration reduced vancomycin-associated nephrotoxicity in mice. These novel findings may indicate that vancomycin-associated nephrotoxicity in humans may be reduced by high-dose VC preadministration.
Collapse
Affiliation(s)
- Masaki Takigawa
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology.,Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital
| | - Tomofumi Yatsu
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology
| | - Yuka Takino
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology
| | | | - Takaaki Kitano
- Department of Anesthesiology, Oita University Faculty of Medicine
| | - Jaewon Lee
- College of Pharmacy, Pusan National University
| | - Tomio Arai
- Department of Pathology, Tokyo Metropolitan Geriatric Hospital
| | - Hiroyuki Tanaka
- Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University
| | - Toshihiro Ishii
- Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University
| | - Yoshiko Mori
- Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital
| | - Akihito Ishigami
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology
| |
Collapse
|
6
|
Miura Y, Fuchigami Y, Nomura S, Nishimura K, Hagimori M, Kawakami S. Brain Microdialysis Study of Vancomycin in the Cerebrospinal Fluid After Intracerebroventricular Administration in Mice. AAPS PharmSciTech 2018; 20:5. [PMID: 30560477 DOI: 10.1208/s12249-018-1232-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Accepted: 10/22/2018] [Indexed: 01/27/2023] Open
Abstract
Vancomycin (VCM) is an important antibiotic for treating methicillin-resistant Staphylococcus aureus (MRSA) infections. To treat bacterial meningitis caused by MRSA, it is necessary to deliver VCM into the meninges, but the rate of VCM translocation through the blood-brain barrier is poor. Additionally, high doses of intravascularly (i.v.) administered VCM may cause renal impairments. Thus, VCM is sometimes administered intracerebroventricularly (i.c.v.) for clinical treatment. However, information on the VCM pharmacokinetics in cerebrospinal fluid (CSF) after i.c.v. administration is lacking. In the present study, we evaluated the VCM pharmacokinetics in the CSF and systemic circulation after i.c.v. compared to that after i.v. administration, using the brain microdialysis method in mice. VCM administered via i.c.v. showed a highly selective distribution in the CSF, without migration to systemic circulation. Moreover, to assess renal impairments after i.c.v. administration of VCM, we histologically evaluated damage to the mouse kidney by hematoxylin and eosin staining. No significant morphological change in the kidney was observed in the i.c.v. administration group compared to that in the i.v. administration group. Our results demonstrate that i.c.v. administration of VCM can be partially prevented from entering the systemic circulation to prevent renal impairments caused by VCM.
Collapse
|
7
|
Takigawa M, Masutomi H, Shimazaki Y, Arai T, Lee J, Ishii T, Mori Y, Ishigami A. Age-dependent changes in vancomycin-induced nephrotoxicity in mice. J Toxicol Pathol 2018; 32:57-66. [PMID: 30739996 PMCID: PMC6361666 DOI: 10.1293/tox.2018-0036] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2018] [Accepted: 10/01/2018] [Indexed: 11/19/2022] Open
Abstract
Vancomycin hydrochloride (VCM) is a glycopeptide antibiotic that is commonly used to eradicate methicillin-resistant gram-positive cocci, despite its nephrotoxic side effects. Elderly people are particularly susceptible to developing VCM-induced nephrotoxicity. However, the precise mechanism by which VCM induces nephrotoxicity in elderly people is not completely understood. Therefore, we investigated VCM-induced nephrotoxicity in mice of different ages. VCM was injected intraperitoneally into mice at 1, 3, 6, 12, and 24 months of age at a dosage of 400 mg/kg body weight for 3 and 14 days. Twenty-four hours after the last injection, we examined plasma creatinine levels and histopathological alterations in the kidneys. VCM administration increased plasma creatinine levels, and these values gradually increased to higher levels with aging. The histological examination revealed renal tubular degeneration, such as brush-border atrophy, apoptosis/necrosis of the tubular epithelium, and epithelial desquamation, that gradually became more severe with aging. Furthermore, immunohistochemical staining with anti-CD10 and anti-single-stranded DNA antibodies revealed damaged renal proximal tubules with marked dilatation, as well as numerous apoptotic cells, and these features increased in severity in 12- and 24-month-old mice receiving VCM. Based on these results, aged mice were highly susceptible to kidney damage induced by VCM administration. In addition, proximal tubular epithelial cells likely underwent apoptosis after the administration of VCM. This report is the first to document VCM-induced nephrotoxicity in mice of different ages. Thus, this mouse model could be useful for understanding the mechanisms of VCM-induced nephrotoxicity in the elderly.
Collapse
Affiliation(s)
- Masaki Takigawa
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan.,Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan
| | - Hirofumi Masutomi
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan
| | - Yoshitomo Shimazaki
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan.,Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan
| | - Tomio Arai
- Department of Pathology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan
| | - Jaewon Lee
- College of Pharmacy, Pusan National University, 2, Busandaehak-ro 63beon-gil, Geumjeong-gu, Busan 46241, Korea
| | - Toshihiro Ishii
- Department of Practical Pharmacy, Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan
| | - Yoshiko Mori
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan.,Department of Pharmacy, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan
| | - Akihito Ishigami
- Molecular Regulation of Aging, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakae-cho, Itabashi-ku, Tokyo 173-0015, Japan
| |
Collapse
|
8
|
Shi H, Zou J, Zhang T, Che H, Gao X, Wang C, Wang Y, Xue C. Protective Effects of DHA-PC against Vancomycin-Induced Nephrotoxicity through the Inhibition of Oxidative Stress and Apoptosis in BALB/c Mice. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2018; 66:475-484. [PMID: 29254330 DOI: 10.1021/acs.jafc.7b04565] [Citation(s) in RCA: 29] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/07/2023]
Abstract
The clinical use of glycopeptide antibiotic vancomycin is usually accompanied by nephrotoxicity, limiting its application and therapeutic efficiency. The aim of this study was to investigate the protection of DHA-enriched phosphatidylcholine (DHA-PC) against nephrotoxicity using a model of vancomycin-induced male BALB/c mice with renal injury by measuring death curves, histological changes, and renal function indexes. The addition of DHA in DHA and DHA-PC groups were 300 mg/kg per day on the basis of human intake level in our study. Results indicated that DHA-PC could dramatically extend the survival time of mice, while traditional DHA and PC had no significant effects. Moreover, oral administration of DHA-PC exhibited better effects on reducing vancomycin-induced increases of blood urea nitrogen, creatinine, cystatin C, and kidney injury molecule-1 levels than traditional DHA and PC. DHA-PC significantly delayed the development of vancomycin-induced renal injury, including tubular necrosis, hyaline casts, and tubular degeneration. A further mechanistic study revealed that the protective effect of DHA-PC on vancomycin-mediated toxicity might be attributed to its ability to inhibit oxidative stress and inactivate mitogen-activated protein kinase (MAPK) signaling pathways, which was associated with upregulation of Bcl-2 and downregulation of caspase-9, caspase-3, cytochrome-c, p38, and JNK. These findings suggest that DHA-PC may be acted as the dietary supplements or functional foods against vancomycin-induced nephrotoxicity.
Collapse
Affiliation(s)
- Haohao Shi
- College of Food Science and Engineering, Ocean University of China , No. 5 Yushan Road, Qingdao, Shandong Province 266003, PR China
| | - Junzhe Zou
- Teaching Center of Fundamental Courses, Ocean University of China , No. 238 Songling Road, Qingdao, Shandong Province 266100, PR China
| | - Tiantian Zhang
- College of Food Science and Engineering, Ocean University of China , No. 5 Yushan Road, Qingdao, Shandong Province 266003, PR China
| | - Hongxia Che
- College of Food Science and Engineering, Ocean University of China , No. 5 Yushan Road, Qingdao, Shandong Province 266003, PR China
| | - Xiang Gao
- College of Life Sciences, Qingdao University , No. 308, Ningxia Road, Qingdao, Shandong Province 266071, PR China
| | - Chengcheng Wang
- College of Food Science and Engineering, Ocean University of China , No. 5 Yushan Road, Qingdao, Shandong Province 266003, PR China
| | - Yuming Wang
- College of Food Science and Engineering, Ocean University of China , No. 5 Yushan Road, Qingdao, Shandong Province 266003, PR China
- Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology , Qingdao, Shandong Province 266237, PR China
| | - Changhu Xue
- College of Food Science and Engineering, Ocean University of China , No. 5 Yushan Road, Qingdao, Shandong Province 266003, PR China
- Laboratory for Marine Drugs and Bioproducts of Qingdao National Laboratory for Marine Science and Technology , Qingdao, Shandong Province 266237, PR China
| |
Collapse
|